Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy
Thyroid Neoplasm - Goiter
Conditions: official terms
Thyroid Neoplasms
Conditions: Keywords
Ropivacaine, Epinephrine, Endoscopy, Robotics, Thyroidectomy
Study Type
Study Phase
Phase 3
Study Design
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Name: Ropivacaine with epinephrine injection
Type: Drug
Overall Status
To assess the pain relief and the hemodynamic stability of ropivacaine with epinephrine in BABA endoscopic and robotic thyroidectomy.
Detailed Description
Diluted ropivacaine with epinephrine is injected into the subcutaneous space to relieve pain and reduce bleeding during procedures. The synergistic effect of ropivacaine with epinephrine can contribute to patients' welfare, such as relieving pain and structuring the hemodynamic stability.
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: 70 Years
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Clinical diagnosis of thyroid neoplasm or benign goiter

- Scheduled for BABA endoscopic or robotic thyroidectomy

Exclusion Criteria:

- Completion thyroidectomy

- Modified radical neck dissection

- Allergy history

- Stroke history

- Uncontrolled hypertension

- Uncontrolled diabetes

- Coagulopathy

- Severe cardiovascular disease

- Severe pulmonary disease

- Chronic kidney disease

- Pregnant
Seoul National University Bundang Hospital
Seongnam, Gyeonggi-do, Korea, Republic of
Status: Recruiting
Contact: Yong Joon Suh, MD - 82-10-4534-1626 - nicizm@gmail.com
Seoul National University Hospital
Seoul, Korea, Republic of
Status: Not yet recruiting
Contact: Yong Joon Suh, MD - 82-10-4534-6126 - nicizm@gmail.com
Start Date
May 2014
Completion Date
May 2016
Seoul National University Hospital
Seoul National University Hospital
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page